SCHEMBL1300545

SCHEMBL1300545

COc1ccc(COc2ccc(/C=C3\SC(=O)NC3=O)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HPGD P15428 8/20 1.00
PTPN1 P18031 4/20 0.77
PIM1 P11309 3/20 0.76
PIM2 Q9P1W9 3/20 0.76
AKR1B1 P15121 1/20 0.76
NPC1 O15118 1/20 0.76
RAB9A P51151 1/20 0.76
POLB P06746 1/20 0.76
MAOA P21397 1/20 0.76
MAOB P27338 1/20 0.76
PTGS2 P35354 1/20 0.65
CISD1 Q9NZ45 1/20 0.65
MMP3 P08254 1/20 0.62
MMP13 P45452 1/20 0.62
ADAMTS5 Q9UNA0 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1300546 1.00 HPGD (1.00) HPGDPTPN1PIM1PIM2AKR1B1
SCHEMBL4050762 0.90 HPGD (0.82) HPGDPTPN1NPC1RAB9APOLB
SCHEMBL4050763 0.90 HPGD (0.82) HPGDPTPN1NPC1RAB9APOLB
SCHEMBL1299453 0.90 HPGD (1.00) HPGDPTPN1PIM1PIM2POLB
SCHEMBL1299451 0.90 HPGD (1.00) HPGDPTPN1PIM1PIM2POLB
SCHEMBL1247705 0.87 PIM1 (1.00) HPGDPIM1PIM2AKR1B1NPC1
SCHEMBL2546911 0.87 PIM1 (1.00) HPGDPIM1PIM2AKR1B1NPC1
SCHEMBL1247708 0.87 PIM1 (1.00) HPGDPIM1PIM2AKR1B1NPC1
SCHEMBL1299645 0.87 HPGD (1.00) HPGDPTPN1PIM1PIM2POLB
SCHEMBL1299641 0.87 HPGD (1.00) HPGDPTPN1PIM1PIM2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2383263-B1 NOVEL THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF UNIV CHOSUN IACF (KR) 2014-04-16 EP disclosed
EP-2383263-B1 NOVEL THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF UNIV CHOSUN IACF (KR) 2014-04-16 EP disclosed
US-8637558-B2 Thiazolidinedione derivative and use thereof INDUSTRY-ACADEMIC COOPERATION FOUNDATION, CHOSUN UNIVERSITY (KR) 2014-01-28 US disclosed
US-8637558-B2 Thiazolidinedione derivative and use thereof INDUSTRY-ACADEMIC COOPERATION FOUNDATION, CHOSUN UNIVERSITY (KR) 2014-01-28 US disclosed
US-20110269954-A1 NOVEL THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF INDUSTRY-ACADEMIC COOPERATION FOUNDATION, CHOSUN UNIVERSITY (KR) 2011-11-03 US disclosed
US-20110269954-A1 NOVEL THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF INDUSTRY-ACADEMIC COOPERATION FOUNDATION, CHOSUN UNIVERSITY (KR) 2011-11-03 US disclosed
EP-2383263-A2 NOVEL THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF Industry-academic Cooperation Foundation, Chosun University (KR) 2011-11-02 EP disclosed
WO-2010077101-A4 NOVEL THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF 조선대학교산학협력단 (KR) 2011-01-13 WO disclosed
WO-2010090458-A2 COMPOSITION FOR CONTROLLING HARMFUL ALGAE 조선대학교산학협력단 (KR) 2010-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269954-A1 NOVEL THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF HPGD, CYP27B1, GCDH HPGD 1/4885PTPN1 2074/4885PIM1 4115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.